Currently the price is 20,12$, Kiniksa Pharmaceuticals Ltd, with address at 2 CHURCH STREET CLARENDON HOUSE, HAMILTON, HM11, Bermuda, is a publicly traded company and its visible heads at the moment are Dana Martin (Senior VP-Global Medical Affairs), Eben P. Tessari (Chief Business Officer), John F. Paolini (Chief Medical Officer & Senior Vice President), Mark Ragosa (Chief Financial Officer & Senior Vice President), Sanj K. Patel (Chairman & Chief Executive Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in Bermuda.
Yesterday this stock ended the day with a value of desconocido$.
With an intraday difference of 20,05$ moving between 19,87$ and 20,23$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
